… makes vaccination possible to control the occurrence of HPV-… HPV vaccines and the
prospective vaccines. It will provide a theoretical basis for further application of the HPV vaccine…

… The effect of HPV vaccines on future cancer incidence will only … running phase III trials with
prophylactic HPV vaccines. … for phase III trials of this prophylactic HPV vaccine (n ¼ 28,000). …

… If HPV vaccination alone is used as a cervical cancer … At this time, prophylactic HPV vaccination
cannot eradicate … in life vaccination with the current prophylactic HPV vaccines followed …

… The prevalence of human papillomavirus (HPV) types varies … of the HPV vaccines is
dependent on the prevalent HPV types. Here, we have studied the prevalence of high-risk HPV (…

… The most common reason for not administering the prophylactic HPV vaccines are concerns
over adverse effects. The aim of this review is the assessment of peer-reviewed scientific …

… prophylactic HPV vaccine. Implementation issues may include how to make the vaccine …
occur, the appropriate age of vaccination, and the role of male vaccination. Because a VLP …

… prophylactic HPV vaccine (HPV6/11/16/18/31/33/45/52/58) is being undertaken. Research
is … directed towards therapeutic vaccines and the development of a prophylactic L2 vaccine. …

… -like particle (VLP) vaccines has encouraged development of several second generation
vaccines aimed at expanding the coverage to all oncogenic HPV types and reducing barriers to …

… prophylactic HPV vaccines culminating in the widespread licensing of two commercial products.
Both vaccines … by the major oncogenic HPV types 16 and 18 and one of the vaccines, in …

… , controlled trials of prophylactic HPV vaccines conducted over many countries … HPV
vaccines24-26. These represent a quadrivalent L1 VLP (HPV types 6, 11, 16, and 18) vaccine under …